Stryker vs. Zimmer Biomet vs. Johnson & Johnson: How they compare in Q2 2023

Stryker, Johnson & Johnson and Zimmer Biomet posted their second quarter financial results for 2023, and data on their orthopedic sales.

Advertisement

Here is how they compare:

Stryker

Total sales: $5 billion (+11.2 percent)

Orthopedics and spine: $2.1 billion (+9.9 percent)

Hips: $393 million (+8.1 percent)

Knees: $562 million (+12.5 percent)

Spine: $296 million (+1.8 percent)

Johnson & Johnson

Total sales: $25.5 billion (+6.3 percent)

Spine, sports and other: $766 million (+5.8 percent)

Orthopedic: $2.3 billion (+5 percent)

Hips: $397 million (+2.2 percent)

Knees: $363 million (+3.9 percent)

Zimmer Biomet

Total sales: $1.8 billion (+4.9 percent)

Hips: $504.3 million (+3.5 percent)

Knees: $771.4 million (+9.4 percent)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $442.7 (-0.8 percent)

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.